Newborn SMA screening study in England
Saturday 1st August, 2026
This is a UK research programme piloting newborn blood‑spot screening for spinal muscular atrophy (SMA) across regional sites in England to test feasibility, uptake and impact on earlier diagnosis and treatment, feeding into national screening policy alongside wider UK activity such as Scotland’s rollout. This gives Lego’s PR team a chance to comment on early childhood health and inclusive play, especially in the UK, where earlier SMA detection changes care pathways for families and can shape conversations about accessible toys and supportive play for children with neurodevelopmental or physical disabilities.
Why have we flagged this?
Strong relevance in the UK: Lego can credibly comment on early childhood health and inclusive play, offer product accessibility initiatives, and share stories or partnerships around supportive play for children diagnosed earlier with SMA.
Get hero story inspiration
Thinking...
Get data story inspiration
Thinking...